Mala Murthy - 01 Mar 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
01 Mar 2024
Transactions value $
-$433,854
Form type
4
Filing time
05 Mar 2024, 16:07:46 UTC
Previous filing
05 Dec 2023
Next filing
20 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +10.6K +21.42% 59.9K 01 Mar 2024 Direct F1
transaction TDOC Common Stock Options Exercise +945 +1.58% 60.8K 01 Mar 2024 Direct F1
transaction TDOC Common Stock Options Exercise +1.88K +3.09% 62.7K 01 Mar 2024 Direct F1
transaction TDOC Common Stock Options Exercise +3.37K +5.37% 66.1K 01 Mar 2024 Direct F2
transaction TDOC Common Stock Options Exercise +2.04K +3.09% 68.1K 01 Mar 2024 Direct F2
transaction TDOC Common Stock Options Exercise +31K +45.51% 99.1K 01 Mar 2024 Direct F2
transaction TDOC Common Stock Options Exercise +2.49K +2.51% 102K 01 Mar 2024 Direct F2
transaction TDOC Common Stock Sale -$434K -29.9K -29.42% $14.52 71.7K 04 Mar 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Performance Stock Units Award $0 +31.7K $0.00 31.7K 01 Mar 2024 Common Stock 31.7K Direct F4, F5, F6
transaction TDOC Performance Stock Units Options Exercise $0 -10.6K -33.33% $0.00 21.1K 01 Mar 2024 Common Stock 10.6K Direct F1, F7
transaction TDOC Performance Stock Units Options Exercise $0 -945 -100% $0.00* 0 01 Mar 2024 Common Stock 945 Direct F1, F8
transaction TDOC Performance Stock Units Options Exercise $0 -1.88K -100% $0.00* 0 01 Mar 2024 Common Stock 1.88K Direct F1, F9
transaction TDOC Restricted Stock Units Options Exercise $0 -3.37K -20% $0.00 13.5K 01 Mar 2024 Common Stock 3.37K Direct F2, F10
transaction TDOC Restricted Stock Units Options Exercise $0 -2.04K -16.67% $0.00 10.2K 01 Mar 2024 Common Stock 2.04K Direct F2, F11
transaction TDOC Restricted Stock Units Options Exercise $0 -31K -33.33% $0.00 62K 01 Mar 2024 Common Stock 31K Direct F2, F12
transaction TDOC Restricted Stock Units Options Exercise $0 -2.49K -100% $0.00* 0 01 Mar 2024 Common Stock 2.49K Direct F2, F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4 Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
F5 Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
F6 The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F7 On March 1, 2024, the reporting person earned 31,696 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F8 On March 2, 2023, the reporting person earned 1,893 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.
F9 On March 2, 2022, the reporting person earned 5,637 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.
F10 On March 1, 2022, the reporting person was granted 40,426 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F11 On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F12 On March 3, 2023, the reporting person was granted 93,006 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F13 On March 2, 2021, the reporting person was granted 7,457 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.